Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3A pseudogene 25 is a **processed pseudogene** located on chromosome 7q21.3 (genomic coordinates: 7:94,695,026-94,695,819)[9][3]. It is derived from the functional RPS3A gene, which encodes a component of the small ribosomal 40S subunit. Pseudogenes like RPS3AP25 arise due to retrotransposition events and resemble the original functional gene but typically contain sequence disruptions (e.g., frameshifts, stop codons) that prevent the formation of a functional protein[6]. RPS3AP25 does not produce a protein and is not involved in cellular processes such as translation or ribosome assembly. It has no established biological function, is not used as a therapeutic target or biomarker, and has no known disease associations[3][7][6].\n\nSummary: RPS3A pseudogene 25 (RPS3AP25) is a non-coding processed pseudogene; it is not a therapeutic target, does not produce a protein, and has no direct biological, clinical, or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3A pseudogene 25 (RPS3AP25).